Cargando…

Current view: indications for extracorporeal lipid apheresis treatment

BACKGROUND: One of the first investigations concerning extracorporeal treatment of hypercholesterolemia was performed in 1967 by plasma exchange in patients with homozygous or severe heterozygous familial hypercholesterolemia (FH). In the following decades, several specific lipid apheresis systems w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schettler, Volker, Neumann, C. L., Hulpke-Wette, M., Hagenah, G. C., Schulz, E. G., Wieland, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374123/ https://www.ncbi.nlm.nih.gov/pubmed/22528134 http://dx.doi.org/10.1007/s11789-012-0046-6

Ejemplares similares

Successful completion of pregnancy using apheresis and a balanced dose of coagulation factors in the presence of high thrombophilia and Lp(a) levels in a woman with two previous abortions
por: Schettler, Volker J.J., et al.
Publicado: (2014)

Lipid apheresis techniques: current status in Germany
por: Grützmacher, Peter, et al.
Publicado: (2012)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
por: Schettler, V. J. J., et al.
Publicado: (2017)

Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias
por: Grützmacher, P., et al.
Publicado: (2015)

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review
por: Lezhnina, Arina, et al.
Publicado: (2022)

Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia
por: Lui, Matthew, et al.
Publicado: (2014)

Lipid apheresis: oxidative stress, rheology, and vasodilatation
por: Mellwig, K.-P., et al.
Publicado: (2012)

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
por: Schettler, Volker J. J., et al.
Publicado: (2015)

Role of lipid apheresis in changing times
por: Schuff-Werner, Peter, et al.
Publicado: (2012)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

Clinical improvement of sepsis by extracorporeal centrifugal leukocyte apheresis in a porcine model
por: Zhou, Lei, et al.
Publicado: (2022)

Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis
por: Weylandt, Karsten-H., et al.
Publicado: (2019)

Frequency and individual severity of arterial blood pressure changes in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate hydrochloride: a prospective non-interventional study
por: Busold-Hagenbeck, Dorothee, et al.
Publicado: (2020)

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
por: Bulut, Muhammet, et al.
Publicado: (2020)

Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
por: Julius, Ulrich
Publicado: (2018)

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
por: Bornstein, Stefan R., et al.
Publicado: (2021)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations
por: Kayser, Stefan, et al.
Publicado: (2020)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
por: Moriarty, Patrick M., et al.
Publicado: (2016)

Extracorporeal life support in cardiogenic shock: indications and management in current practice
por: Meuwese, C. L., et al.
Publicado: (2018)

Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
por: Russi, Gianpaolo, et al.
Publicado: (2009)

Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience)
por: Kolovou, Genovefa, et al.
Publicado: (2012)

Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion
por: Duchez, Anne-Claire, et al.
Publicado: (2023)

Apheresis: What Should a Clinician Know?
por: Parhofer, Klaus G.
Publicado: (2023)

Extracorporeal support for pulmonary resection: current indications and results
por: Rosskopfova, Petra, et al.
Publicado: (2016)

Therapeutic apheresis in autoimmune diseases
por: Bambauer, Rolf, et al.
Publicado: (2013)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
por: Lischka, Julia, et al.
Publicado: (2022)

Helium atom scattering from surfaces
por: Hulpke, E
Publicado: (1992)

LDL-Apheresis: Technical and Clinical Aspects
por: Bambauer, Rolf, et al.
Publicado: (2012)

Leukocyte Apheresis in the Management of Ulcerative Colitis
por: Helmy, Ahmed, et al.
Publicado: (2009)

Hyperlipoproteinaemia(a) – apheresis and emerging therapies
por: Vogt, Anja
Publicado: (2017)

Apheresis in Autoimmune Encephalitis and Autoimmune Dementia
por: Rössling, Rosa, et al.
Publicado: (2020)

Safety of Therapeutic Apheresis in Children and Adolescents
por: Taylan, Christina, et al.
Publicado: (2022)

Principles of Therapeutic Apheresis in Neurological Disease
por: Strasser, Erwin
Publicado: (2023)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_seht198gj7j8jj6g4ode1fivqm